Literature DB >> 18722607

Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS.

Melanie Landay1, Andy Huang, Ricardo Azziz.   

Abstract

OBJECTIVE: To determine whether the severity in hyperandrogenemia determines, to a significant degree, the severity of hirsutism in patients with polycystic ovary syndrome (PCOS).
DESIGN: Cross-sectional study.
SETTING: Tertiary care academic referral center. PATIENT(S): A total of 749 patients with PCOS. INTERVENTION(S): History and physical examination, blood sampling. MAIN OUTCOME MEASURE(S): Hirsutism defined by a value of >or=6 using the modified Ferriman-Gallwey (mFG) score, age, body mass index (BMI), calculated homeostatic assessment for insulin resistance (HOMA-IR) value, and levels of total (TT) and free (FT) testosterone, dehydroepiandrosterone sulfate (DHEAS) 17-hydroxyprogesterone (17OH-P), and fasting insulin (INS) and glucose (GLC). RESULT(S): Univariate correlations revealed associations between the mFG score and INS, 17OH-P, HOMA-IR, and BMI. Multivariate classification and regression tree analysis indicated that INS had the most significant association with mFG score and that at higher INS levels T played an additional role whereas at lower INS levels 17OH-P had an effect; however, this model accounted for only 8.2% of total variation in mFG score. CONCLUSION(S): Insulin appears to have a direct effect on the severity of hirsutism in PCOS and appears to have a synergistic interaction with TT. Notably, over 90% of the variation in the mFG score was not related to the factors studied and likely reflects intrinsic factors related to pilosebaceous unit function or sensitivity and to other factors not yet assessed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722607      PMCID: PMC3714600          DOI: 10.1016/j.fertnstert.2008.06.021

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.

Authors:  Gordon Guyatt; Bruce Weaver; Lisa Cronin; Julie Ann Dooley; Ricardo Azziz
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

Review 2.  Whole hair follicle culture.

Authors:  M P Philpott; D A Sanders; T Kealey
Journal:  Dermatol Clin       Date:  1996-10       Impact factor: 3.478

3.  Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.

Authors:  Wendy Y Chang; Eric S Knochenhauer; Alfred A Bartolucci; Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

4.  Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells.

Authors:  A Singh; D Hamilton-Fairley; R Koistinen; M Seppälä; V H James; S Franks; M J Reed
Journal:  J Endocrinol       Date:  1990-02       Impact factor: 4.286

5.  Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability.

Authors:  L R Boots; S Potter; D Potter; R Azziz
Journal:  Fertil Steril       Date:  1998-02       Impact factor: 7.329

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  The investigation of insulin resistance in patients with idiopathic hirsutism.

Authors:  Kürsad Unlühizarci; Yesim Karababa; Fahri Bayram; Fahrettin Kelestimur
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Authors:  E S Knochenhauer; T J Key; M Kahsar-Miller; W Waggoner; L R Boots; R Azziz
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  The relationship of mild hirsutism or acne in women to androgens.

Authors:  S B Reingold; R L Rosenfield
Journal:  Arch Dermatol       Date:  1987-02
View more
  19 in total

Review 1.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

2.  Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?

Authors:  Heather Cook; Kathleen Brennan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2011-09-15       Impact factor: 7.329

3.  Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.

Authors:  Uche Ezeh; Andy Huang; Melanie Landay; Ricardo Azziz
Journal:  J Womens Health (Larchmt)       Date:  2018-06-07       Impact factor: 2.681

4.  Insulin signaling displayed a differential tissue-specific response to low-dose dihydrotestosterone in female mice.

Authors:  Stanley Andrisse; Katelyn Billings; Ping Xue; Sheng Wu
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-19       Impact factor: 4.310

5.  Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.

Authors:  M A Pappalardo; R Vita; F Di Bari; M Le Donne; F Trimarchi; S Benvenga
Journal:  J Endocrinol Invest       Date:  2016-10-26       Impact factor: 4.256

6.  Predictors of pregnancy in women with polycystic ovary syndrome.

Authors:  Mary E Rausch; Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers; Christos Coutifaris
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

7.  Lifestyle changes in women with polycystic ovary syndrome.

Authors:  Siew S Lim; Samantha K Hutchison; Emer Van Ryswyk; Robert J Norman; Helena J Teede; Lisa J Moran
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28

8.  Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder.

Authors:  Christine Brady; Shaymaa S Mousa; Shaker A Mousa
Journal:  Drug Healthc Patient Saf       Date:  2009-02-03

9.  Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study.

Authors:  José Gomes Batista; José Maria Soares; Carla Cristina Maganhin; Ricardo Santos Simões; Geraldez Tomaz; Edmund Chada Baracat
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.

Authors:  Yanhua Zheng; Jingwei Yu; Chengjie Liang; Shuna Li; Xiaohui Wen; Yanmei Li
Journal:  Bioprocess Biosyst Eng       Date:  2020-03-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.